COVID-19 and Smoking

1Département de pharmacologie, Hôpital Pitié-Salpêtrière, Paris, France; 2Centre Universitaire de Médecine Générale et Santé Publique, UNISANTE, Université de Lausanne, Lausanne, Switzerland; 3Institut de Cardiologie, Hôpital PitiéSalpêtrière, Paris, France; 4Centre ambulatoire d’addictologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Centre, Fédération Hospitalo-Universitaire Network of Research in Substance Use Disorder, Université de Paris, Paris, France

[1]  F. Alla,et al.  Tobacco and COVID-19: a crisis within a crisis? , 2020, Canadian Journal of Public Health.

[2]  N. Benowitz,et al.  Cigarette smoking and infection. , 2004, Archives of internal medicine.

[3]  G. Lippi,et al.  Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) , 2020, European Journal of Internal Medicine.

[4]  G. Joos,et al.  DPP4, the MERS coronavirus receptor, is upregulated in lungs of smokers and COPD patients. , 2017 .

[5]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[6]  N. Kabbani,et al.  Is nicotine exposure linked to cardiopulmonary vulnerability to COVID‐19 in the general population? , 2020, The FEBS journal.

[7]  N. Jaafari,et al.  Tabagisme et maladie à coronavirus 2019 (COVID-19) , 2020, Revue des Maladies Respiratoires.

[8]  Joanna Ellis,et al.  Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study , 2020, The Lancet Infectious Diseases.

[9]  S. Glantz,et al.  Smoking is Associated with COVID-19 Progression: A Meta-Analysis , 2020, medRxiv.

[10]  K. Farsalinos,et al.  Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system , 2020, Toxicology Reports.

[11]  Jason M. Sheltzer,et al.  Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract , 2020, bioRxiv.

[12]  O. Perski,et al.  The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 3) , 2020, Qeios.

[13]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[14]  C. Vardavas,et al.  COVID-19 and smoking: A systematic review of the evidence , 2020, Tobacco induced diseases.

[15]  G. Cai.  Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov , 2020, medRxiv.

[16]  Mohammad A. Almazroa,et al.  Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014 , 2016, Emerging infectious diseases.

[17]  F. Tubach,et al.  Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19 , 2020, Qeios.

[18]  Wei Liu,et al.  Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease , 2020, Chinese medical journal.

[19]  Ting Yu,et al.  Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.

[20]  K. Bhaskaran,et al.  OpenSAFELY: factors associated with COVID-19 death in 17 million patients , 2020, Nature.

[21]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[22]  O. Perski,et al.  The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 5) , 2020, Qeios.

[23]  C. Rentsch,et al.  Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54–75 Years , 2020, medRxiv.

[24]  J. Changeux,et al.  A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. , 2020, Comptes rendus biologies.

[25]  W. Feleszko,et al.  Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review , 2018, International journal of environmental research and public health.

[26]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[27]  Jieun Park,et al.  MERS transmission and risk factors: a systematic review , 2018, BMC Public Health.

[28]  P. Gallian,et al.  Cluster of COVID-19 in northern France: A retrospective closed cohort study , 2020, medRxiv.

[29]  J. Sterne,et al.  Collider bias undermines our understanding of COVID-19 disease risk and severity , 2020, Nature Communications.

[30]  H. Nam,et al.  High fatality rates and associated factors in two hospital outbreaks of MERS in Daejeon, the Republic of Korea , 2017, International Journal of Infectious Diseases.

[31]  Cdc Covid- Response Team.  Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 — United States, February 12–March 28, 2020 , 2020 .

[32]  Ankur Khajuria,et al.  The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis , 2020, Journal of medical virology.

[33]  Lei Wu,et al.  Changes in and Patterns of Smoking Exposure in an Elderly Urban Population in Beijing: 2001–2010 , 2015, PloS one.

[34]  N. Volkow,et al.  COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States , 2020, Molecular Psychiatry.

[35]  Robert Fuchs,et al.  Nicotine and the renin-angiotensin system. , 2018, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[37]  David K. Vawdrey,et al.  Challenges with Collecting Smoking Status in Electronic Health Records , 2017, AMIA.

[38]  Y. Bossé,et al.  Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2 , 2020, American journal of respiratory and critical care medicine.